Diclofenac and metabolite pharmacokinetics in children

Paediatric Anaesthesia

Volumn 14, Issue 6, 2004, Pages 443-451

  Van Der Marel, Caroline D ^a   Anderson, Brian J ^b,e   Rømsing, Janne ^c   Jacqz Aigrain, Evelyne ^d   Tibboel, Dick ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e STARSHIP CHILDREN S HOSPITAL   (New Zealand)

Author keywords

Children; Diclofenac; Metabolites; Pharmacokinetics

Indexed keywords

4' HYDROXYDICLOFENAC; 5' HYDROXYDICLOFENAC; DICLOFENAC; DICLON; DRUG METABOLITE; HYDROXYL GROUP; UNCLASSIFIED DRUG;

ADOLESCENT; ALLOMETRY; ARTICLE; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; ENTERIC COATED TABLET; HUMAN; PEDIATRIC ANESTHESIA; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SERUM; STANDARDIZATION; SUPPOSITORY; TONSILLECTOMY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DICLOFENAC; FEMALE; HALF-LIFE; HUMANS; MALE; PAIN, POSTOPERATIVE; RECTUM; SUPPOSITORIES; TABLETS, ENTERIC-COATED; TONSILLECTOMY;

EID: 2942517657     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2004.01232.x     Document Type: Article

References (39)

1. Litalien C, Jacqz-Aigrain E. Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol. Paediatr Drugs 2001; 3: 817-858.
2. Rømsing J, Ostergaard D, Drozdziewicz D et al. Diclofenac or acetaminophen for analgesia in paediatric tonsillectomy outpatients. Acta Anaesthesiol Scand 2000; 44: 291-295.
3. Rømsing J, Ostergaard D, Senderovitz T et al. Pharmacokinetics of oral diclofenac and acetaminophen in children after surgery. Paediatr Anaesth 2001; 11: 205-213.
4. Rømsing J, Moiniche S, Dahl JB. Rectal and parenteral paracetamol, and paracetamol in combination with NSAIDs, for postoperative analgesia. Br J Anaesth 2002; 88: 215-226.
5. Rømsing J, Walther-Larsen S. Peri-operative use of nonsteroidal anti-inflammatory drugs in children: analgesic efficacy and bleeding. Anaesthesia 1997; 52: 673-683.
6. Rømsing J, Ostergaard D, Walther-Larsen S et al. Analgesic efficacy and safety of preoperative versus postoperative ketorolac in paediatric tonsillectomy. Acta Anaesthesiol Scand 1998; 42: 770-775.
7. Moiniche S, Rømsing J, Dahl JB et al. Nonsteroidal antiinflammatory drugs and the risk of operative site bleeding after tonsillectomy: a quantitative systematic review. Anesth Analg 2003; 96: 68-77.
8. Tawalbeh MI, Nawasreh OO, Husban AM. Comparative study of diclofenac sodium and paracetamol for treatment of pain after adenotonsillectomy in children. Saudi Med J 2001; 22: 121-123.
9. Thiagarajan J, Bates S, Hitchcock M et al. Blood loss following tonsillectomy in children. A blind comparison of diclofenac and papaveretum. Anaesthesia 1993; 48: 132-135.
10. Walmsley AJ. Peri-operative use of nonsteroidal anti-inflammatory drugs in children. Anaesthesia 1997; 52: 1120.
11. Korpela R, Olkkola KT. Pharmacokinetics of intravenous diclofenac sodium in children. Eur J Clin Pharmacol 1990; 38: 293-295.
12. Davies NM, Anderson KE. Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet 1997; 33: 184-213.
13. Haapasaari J, Wuolijoki E, Ylijoki H. Treatment of juvenile rheumatoid arthritis with diclofenac sodium. Scand J Rheumatol 1983; 12: 325-330.
14. Stierlin H, Faigle JW. Biotransformarion of diclofenac sodium (Voltaren) in animals and in man. II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile. Xenobiotica 1979; 9: 611-621.
15. Stierlin H, Faigle JW, Sallmann A et al. Biotransformarion of diclofenac sodium (Voltaren) in animals and in man. I. Isolation and identification of principal metabolites. Xenobiotica 1979; 9: 601-610.
16. Bort R, Ponsoda X, Carrasco E et al. Metabolism of aceclofenac in humans. Drug Metab Dispos 1996; 24: 834-841.
17. Menasse R, Hedwall PR, Kraetz J et al. Pharmacological properties of diclofenac sodium and its metabolites. Scand J Rheumatol Suppl 1978; 22: 5-16.
18. Landsdorp D, Vree TB, Janssen TJ et al. Pharmacokinetics of rectal diclofenac and its hydroxy metabolites in man. Int J Clin Pharmacol Ther Toxicol 1990; 28: 298-302.
19. Holford NHG. A size standard for pharmacokinetics. Clin Pharmacokinet 1996; 30: 329-332.
20. Peters HP. Physiological correlates of size. In: Beck E, Birks HJB, Conner EF, eds. The Ecological Implications of Body Size. Cambridge: Cambridge University Press, 1983: 48-53.
21. West GB, Brown JH, Enquist BJ. A general model for the origin of allometric scaling laws in biology. Science 1997; 276: 122-126.
22. West GB, Brown JH, Enquist BJ. The fourth dimension of life: fractal geometry and allometric scaling of organisms. Science 1999; 284: 1677-1679.
23. Anderson BJ, Meakin GH. Scaling for size: some implications for paediatric anaesthesia dosing. Paediatr Anaesth 2002; 12: 205-219.
24. Troconiz IF, Armenteros S, Planelles MV et al. Pharmacokinetic- pharmacodynamic modelling of the antipyretic effect of two oral formulations of ibuprofen. Clin Pharmacokinet 2000; 38: 505-518.
25. Dsida RM, Wheeler M, Birmingham PK et al. Age-stratified pharmacokinetics of ketorolac tromethamine in pediatric surgical patients. Anesth Analg 2002; 94: 266-270.
26. Boni J, Korth-Bradley J, McGoldrick K et al. Pharmacokinetic and pharmacodynamic action of etodolac in patients after oral surgery. J Clin Pharmacol 1999; 39: 729-737.
27. van Hoogdalem E, de Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration, Part I. General considerations and clinical applications of centrally acting drugs. Clin Pharmacokinet 1991; 21: 11-26.
28. van Hoogdalem EJ, de Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions. Clin Pharmacokinet 1991; 21: 110-128.
29. Gleiter CH, Antonin KH, Bieck P et al. Colonoscopy in the investigation of drug absorption in healthy volunteers. Gastrointest Endosc 1985; 31: 71-73.
30. Riess W, Stierlin H, Degen P et al. Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren. Scand J Rheumatol Suppl 1978; 22: 17-29.
31. Kendall MJ, Thornhill DP, Willis JV. Factors affecting the pharmacokinetics of diclofenac sodium (Voltarol). Rheumatol Rehabil 1979; Suppl: 38-46.
32. John VA. The pharmacokinetics and metabolism of diclofenac sodium (Voltarol) in animals and man. Rheumatol Rehabil 1979; Suppl: 22-37.
33. Willis JV, Kendall MJ, Flinn RM et al. The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur J Clin Pharmacol 1979; 16: 405-410.
34. Scaroni C, Mazzoni PL, D'Amico E et al. Pharmacokinetics of oral and rectal flurbiprofen in children. Eur J Clin Pharmacol 1984; 27: 367-369.
35. Wiesenberg-Boettcher I, Pfeilschifter J, Schweizer A et al. Pharmacological properties of five diclofenac metabolites identified in human plasma. Agents Actions 1991; 34: 135-137.
36. Mandema JW, Stanski DR. Population pharmacodynamic model for ketorolac analgesia. Clin Pharmacol Ther 1996; 60: 619-635.
37. Anderson BJ, Woollard GA, Holford NHG. Acetaminophen analgesia in children: placebo effect and pain resolution after tonsillectomy. Eur J Clin Pharmacol 2001; 57: 559-569.
38. Brocks DR, Jamali F. Clinical pharmacokinetics of ketorolac tromethamine. Clin Pharmacokinet 1992; 23: 415-427.
39. Anderson BJ, Woollard GA, Holford NHG. A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children. Brit J Clin Pharmacol 2000; 50: 125-134.